Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

Fig. 2

Kaplan–Meier curves for time to PSA progression in JPN-201. a green, PSA ≤ −30 % (30 %-decline); blue, −30 % < PSA < 25 % (non-decline); red, PSA ≥ 25 % (25 %-elevation) according to PSA change at week 4. b green, PSA response (≥50 %); blue, PSA non-response/progression; red, PSA progression according to PSA response at week 12

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us